These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 10864193

  • 1. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M, Ruiz P, Herreras A.
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193
    [Abstract] [Full Text] [Related]

  • 2. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY, Bilgin K, Uzun M, Durupinar B.
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [Abstract] [Full Text] [Related]

  • 3. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R, Cöplü N, Ceyhan I, Ocak F, Citil BE, Esen B.
    Mikrobiyol Bul; 2006 Apr; 40(1-2):1-7. PubMed ID: 16775950
    [Abstract] [Full Text] [Related]

  • 4. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995.
    Bercion R, Kuaban C.
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073
    [Abstract] [Full Text] [Related]

  • 5. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER, Tupasi TE, Rivera AB, Quelapio MI, Cardaño RC, Derilo JO, Belen VA.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [Abstract] [Full Text] [Related]

  • 6. [Primary resistance of Mycobacterium tuberculosis in 10 hospitals of the community of Castille and Leon. Group of Microbiologists from Castille and Leon].
    Alberte Castiñeiras A, Pérez Pascual P.
    Rev Clin Esp; 1999 Mar; 199(3):132-5. PubMed ID: 10230290
    [Abstract] [Full Text] [Related]

  • 7. [A preliminary study on the definition of resistant breakpoints of ofloxacin and levofloxacin for Mycobacterium tuberculosis].
    Huang XR, Gao WW, Zhang XX, Wang SM, Pan YX, Ma Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):84-8. PubMed ID: 14990180
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
    Sun Z, Zhang J, Zhang X, Wang S, Zhang Y, Li C.
    Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Feb; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 12. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A, Kawata N, Shibayama T, Takahashi S, Hirano A, Kimura G, Takeuchi M, Okada C, Soda R, Takahashi K.
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [Abstract] [Full Text] [Related]

  • 13. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A, Rigouts L, Shamputa IC, Dediste A, Struelens M, Portaels F.
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [Abstract] [Full Text] [Related]

  • 14. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
    Verma JS, Nair D, Rawat D, Manzoor N.
    Indian J Med Microbiol; 2011 Mar; 29(3):280-2. PubMed ID: 21860110
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin].
    Cavuşoğlu C, Ciçek-Saydam C, Burhanoğlu D, Ozkalay N, Ozkaya D, Ozçam H, Bilgiç A.
    Mikrobiyol Bul; 2002 Jan; 36(1):118-23. PubMed ID: 12476777
    [Abstract] [Full Text] [Related]

  • 16. Primary resistance to antituberculosis drugs: a national survey conducted in Côte d'Ivoire in 1995-1996. Ivoirian Study Group on Tuberculosis Resistance.
    Dosso M, Bonard D, Msellati P, Bamba A, Doulhourou C, Vincent V, Peyre M, Traore M, Koffi K, Coulibaly IM.
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):805-9. PubMed ID: 10488889
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.